Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-10-03
2006-10-03
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C544S244000
Reexamination Certificate
active
07115590
ABSTRACT:
The present invention relates to phosphoramidate, and phosphate esters of (1R,cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1nethanol, processes for their preparation, and their use in treating viral infections.
REFERENCES:
patent: 5244896 (1993-09-01), Borcherding et al.
patent: 6455513 (2002-09-01), McGuigan et al.
patent: 6638919 (2003-10-01), McGuigan et al.
patent: 6828319 (2004-12-01), Jagtap et al.
patent: 6887707 (2005-05-01), Loeb et al.
patent: 2003/0045508 (2003-03-01), Daluge et al.
Kim, J. Med Chem 33, 1207 (1990).
Semizarov et al.: “Selectivity of DNA Polymerases toward alpha and beta Nucleotide Substrates of D and L series” FEBS LETT., vol. 354, No. 2, Nov. 7, 1994, pp. 187-190.
Faletto et al.: “Unique Intracellular Activation of the Potent Anti-Human Immundeficiency Virus Agent 1592U89” Antimicrobial Agents and Chemotherapy, vol. 41, No. 5, May 1997, pp. 1099-1107.
Daluge Susan Mary
McGuigan Christopher
Berch Mark L.
Mathews, Shepherd, McKay & Bruneau, P.A.
University College Cardiff Consultants Limited
LandOfFree
Phosphoramidate, and mono-, di-, and tri-phosphate esters of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphoramidate, and mono-, di-, and tri-phosphate esters of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphoramidate, and mono-, di-, and tri-phosphate esters of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3688729